XML 36 R25.htm IDEA: XBRL DOCUMENT v3.25.0.1
NET INCOME (LOSS) PER SHARE
 9 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
NET INCOME (LOSS) PER SHARE NET INCOME (LOSS) PER SHARE
Calculations of the basic and diluted net income (loss) per share and potential common shares are as follows (in thousands, except for per share data):
Three Months EndedNine Months Ended
 December 31,December 31,
 2024202320242023
Numerator:
Net income (loss)$48,810 $(132,577)$(385,539)$(115,315)
Denominator:
Denominator for basic net income (loss) per share - weighted average common shares outstanding
71,737 71,077 71,551 71,577 
Dilutive common equivalent shares:
Weighted average restricted stock units and performance-based restricted stock units832 — — — 
Denominator for diluted net income (loss) per share - weighted average shares outstanding
72,569 71,077 71,551 71,577 
Net income (loss) per share:
     Basic net income (loss) per share$0.68 $(1.87)$(5.39)$(1.61)
     Diluted net income (loss) per share$0.67 $(1.87)$(5.39)$(1.61)
The following table sets forth restricted stock units excluded from the calculation of diluted net income (loss) per share, since their inclusion would be anti-dilutive (in thousands):
Three Months EndedNine Months Ended
 December 31,December 31,
 2024202320242023
Restricted stock units1,944 561 534 778 
Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding during the period. Unvested restricted shares, although legally issued and outstanding, are not considered outstanding for purposes of calculating basic earnings per share. Diluted net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of shares outstanding plus the dilutive effect, if any, of outstanding stock options, restricted shares and restricted stock units using the treasury stock method. The calculation of the dilutive effect of outstanding equity awards under the treasury stock method includes consideration of proceeds from the assumed exercise of stock options and unrecognized compensation expense as additional proceeds. As the Company incurred a net loss during the three months ended December 31, 2023, and the nine months ended December 31, 2024 and 2023, all outstanding restricted stock units and performance-based restricted stock units have an anti-dilutive effect and are therefore excluded from the computation of diluted weighted average shares outstanding.